Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
11/6/2022
Germany Pharma CEOs Visit China with German Chancellor Scholz
11/4/2022
NMPA Announces Package Insert Revision of Methotrexate Oral Formulatio...
11/4/2022
Recent Executive Moves
11/4/2022
Drug R&D and Product Registration News Digest November 2022 (1)
11/4/2022
China Clarifies Regulations for Online Prescription Drug Sales, But Th...
11/4/2022
The Race To The Bottom In The Chinese Pharmaceutical Market Reinforces...
11/3/2022
NMPA Releases the Draft List of Drugs Prohibited for Online Sales for ...
11/3/2022
Global Data: Small Molecule Renaissance in Rare Diseases for China's B...
11/3/2022
45 Orphan Drugs Included in China's Latest National Drug Reimbursemne...
11/2/2022
CDE Issues the Technical Guidelines for Design and Evaluation of Pedia...
11/2/2022
NMPA Announces Package Insert Revision of Liver Hydrolyzed Peptide Inj...
11/1/2022
NMPA Initiates New Certification Documents for APIs and Drug Exports
11/1/2022
TPG Capital Asia Acquires Majority Stake in iNova Pharmaceuticals
11/1/2022
Pharmaniaga Partners JD.com to Enter China Healthcare Market
11/1/2022
Invincible Diabetes Turns APAC Into Pharma Goldmine (BioSpectrum)
11/1/2022
China Bars Celebrities from Endorsing Products to Boost 'Traditional V...
10/31/2022
Yes! It's Now Time to Reconfigure Your China Business Model Again
10/31/2022
Big Pharma Dominated the Deals Space in September (PharmaDJ)
10/31/2022
Financial-related Company News Digest (October 2022)
10/31/2022
Novartis Abandons US PD-1 Submission Plan for Tislelizumab
10/31/2022
NMPA Suspends Import, Sales and Use of GSK's Prostate Cancer Drug Avod...
10/31/2022
JPO Bans GSK from Participating in China's National Level Centralized ...
10/30/2022
Ascletis Pharma Ends Down After Pfizer Supply Deal Sent Stock Soaring
10/28/2022
CDE Publicizes the List of Reference Formulations for GQCE Studies (64...
10/28/2022
Recent Executive Moves
10/28/2022
Drug R&D and Product Registration News Digest October 2022 (3)
10/28/2022
XtalPi Announces Research Collaboration with Janssen
10/27/2022
NMPA Announces Package Insert Revision of Domperidone Formulations
10/27/2022
CDE Solicits Comments on Draft Work Standards for Review of Drug Clini...
10/27/2022
Salubris and Anlong Bio Enter Partnership for Small Nucleic Acid Dru...
Page:
67
/
719
Total number of articles:
21546
:
[First]
[<<]
[65]
[66]
[67]
[68]
[69]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit